Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Lauroyl Polyoxyethylene Glycerol Ester stands out as a valuable non-ionic surfactant in the world of pharmaceutical excipients. The material comes together from lauric acid, glycerol, and ethylene oxide, forming a compound known for balancing hydrophilic and lipophilic properties. Its structure allows it to play a vital part in formulations as an emulsifier and solubilizer, supporting stable dispersions for a range of drug delivery systems. Each segment of this ester — the lauroyl chain, the polyoxyethylene moiety, and the glycerol backbone — brings something unique to its solubility, interaction with other molecules, and safety profile.
Working with Lauroyl Polyoxyethylene Glycerol Ester, you notice the variety in its forms. The material might come as a white to off-white solid, sometimes as flakes or pearls, or in a creamy paste. The structure reveals repeating ethylene oxide units, which dictate much of its hydrophilicity and surface-active nature. On a molecular level, the average molecular formula depends on the degree of polymerization, with common grades containing about 20 to 25 ethylene oxide units linked to the lauroyl-glycerol esters. Specifications often include a hydroxyl value, saponification value, and an acid value, all reflecting its purity and consistency batch to batch. Most grades keep moisture content low, often below 2%, making storage and handling straightforward.
Packing this ester into containers for transport or use, the density tends to hover near 1.05 grams per cubic centimeter for the solid form. In powder form, bulk density can look quite different, usually between 0.30 to 0.50 grams per cubic centimeter. Some suppliers ship it as clear to slightly opalescent liquids, especially if blended with water or solvents, though most pharmaceutical applications prefer the solid or flaked material. Temperature shifts influence consistency. Below 30°C the substance remains solid or semi-solid, but above that it slowly turns into a flowable paste or low-viscosity liquid, which simplifies mixing. Because the ester carries a high degree of purity, it easily qualifies for BP, EP, and USP monographs, yet always requires close inspection with every new lot.
Shipping and import duties fall under harmonized nomenclature. The commonly used HS Code for a non-ionic surfactant like Lauroyl Polyoxyethylene Glycerol Ester usually falls within the 3402 category. Knowing the exact subheading (often 3402.13 for non-ionic organic surface-active agents) avoids custom hold-ups and ensures regulatory compliance, especially when raw materials and finished pharmaceutical products move across borders. Documentation usually accompanies product shipments, listing batch number, specifications, safety data, and origin, which minimizes mix-ups and speeds up quality checks.
Safety sits front and center in labs and production sites. Lauroyl Polyoxyethylene Glycerol Ester has built its reputation on a broad margin of safety when used as directed in pharmaceutical formulations. Most suppliers classify it as non-toxic and non-hazardous for standard use, yet the Safety Data Sheet (SDS) will point out mild irritant properties in its powder form, especially if contacted with sensitive skin or eyes. Inhalation risk runs low due to low dusting, but gloves and goggles come in handy during weighing and blending. Disposal generally follows standard chemical waste guidelines. No significant environmental persistence or bioaccumulation issues have shown up in studies, especially compared to other surfactants with less favorable ecological profiles.
Glycerol and lauric acid, the principal starting materials, trace back to palm and coconut sources, bringing along sustainability concerns that have to be managed with informed sourcing. Polyoxyethylene chains derive from ethylene oxide, a petrochemical derivative, linking this excipient’s production to the broader upstream chemical industry. These connections put pressure on pricing and availability, especially during supply chain disruptions or shifts in crude oil markets. Strict regulatory oversight, especially for pharmaceutical-grade supply, drives suppliers to invest in high-purity feedstocks and validated processes. Documentation trails extend from raw material supplier right to finished excipients, supporting safety, quality, and transparency.
Not every surfactant can match the unique combination of low irritation, reliable emulsification, and gentle action that Lauroyl Polyoxyethylene Glycerol Ester brings to oral, topical, and parenteral products. The specific arrangement of lauroyl chain and oxyethylene units builds a molecule that straddles both water and oil domains with ease. This molecular structure directly affects HLB (hydrophilic–lipophilic balance), usually falling between 12 and 15 depending on the ethylene oxide content, which influences its choice for cream, suspension, or solution systems. In real-world applications, dense technical data supports a product’s quality and performance, but experience with formulation performance always proves invaluable for verifying those numbers onsite.
Formulators looking to solve solubility and bioavailability challenges respect this ester for helping drugs disperse evenly and deliver consistently. Taking on tough-to-dissolve actives, the ester pairs well with other surfactants and co-solvents, often improving drug stability and patient acceptability. As regulatory expectations rise, the demand for robust, traceable ingredients grows. Investing in open supply chains, transparent testing, and supplier qualification can reduce risk and enhance patient safety. Shifts toward green chemistry could encourage manufacturers to explore alternative routes for sourcing polyols or plant-based fatty acids, trading short-term cost for long-term resilience and responsibility.
Chengguan District, Lanzhou, Gansu, China
